FARMINGDALE, N.Y., Aug. 10, 2011 /PRNewswire/ -- Misonix, Inc. (NASDAQ: MSON), a medical device company that designs, manufactures and markets innovative therapeutic ultrasonic products worldwide for wound debridement, spinal surgery, cosmetic surgery, neurosurgery, laparoscopic surgery, and other surgical and medical applications, has announced its immediate entry into surgical wound debridement by adding their SonicOne® technology to the BoneScalpel™ surgical platform. The BoneScalpel with SonicOne Technology is designed for surgical wound debridement and is an updated and expanded version of the Company's existing BoneScalpel product. The SonicOne Wound Debridement System has been marketed by the Company to free-standing wound clinics, hospital-based wound clinics, and long term acute care hospitals for several years.
Misonix's has completed product training with its domestic sales force on the BoneScalpel with SonicOne Technology; training of its international distributors is scheduled on a country by country basis over the next several months. Reimbursement is available for surgical debridement in the U.S. market. The Company's strategy is to market a range of products to effect a complete wound healing protocol for surgery. The BoneScalpel with SonicOne Technology is a companion product to the recently announced Hyalomatrix® skin substitute and will be positioned accordingly.
Wound cleansing and debridement procedures done in the Operating Room include trauma cases, burns, and chronic wound cases that have escalated beyond the capabilities of the wound clinic. In concert with the release of the BoneScalpel with SonicOne Technology, the Company has also begun marketing a comprehensive line of specialty disposables.
The stand-alone SonicOne is an innovative, ultrasonic wound care system that offers tissue specific debridement and cleansing for effective removal of devitalized tissue and fibrin deposits while sparing viable cellular structures. The Company believes that the SonicOne establishes a new standard in advanced wound care and ensures progress towards patient healing.
Select the service that is right for you!COMPARE ALL SERVICES
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
- Weekly roundups
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Upgrade/downgrade alerts
- Diversified model portfolio of dividend stocks
- Alerts when market news affect the portfolio
- Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
- Real Money + Doug Kass + 15 more Wall Street Pros
- Intraday commentary & news
- Ultra-actionable trading ideas
- 100+ monthly options trading ideas
- Actionable options commentary & news
- Real-time trading community
- Options TV